Leiden University Medical Centre – LUMC is a university medical centre for research, education and patient care with a high quality profile and a strong scientific orientation. It has a unique research practice, ranging from pure fundamental medical research to applied clinical research. LUMC is a centre for medical innovation, committed to the advancement of healthcare and education in line with the latest international insights and standards, and aims to play a nationally and internationally recognized leading role in improving medicine and the quality of healthcare.
LUMC will fulfil its tasks within WP6.
– recruit HD patients and healthy controls for the clinical validation study
– coordinate study management at the site
– ensuring compliance and principles of GCP during conduct of the study
Target recruitment:
• Huntington’s Disease – 35
• Healthy controls – 10
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.